Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05968547
Other study ID # B00964
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 25, 2023
Est. completion date December 25, 2023

Study information

Verified date July 2023
Source Manchester University NHS Foundation Trust
Contact Subash Sukumar
Phone 0161-276-6583
Email subash.sukumar@mft.nhs.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Glaucoma can affect both central and peripheral vision. Clinicians need to discuss with patients the vision related driving standards and any specific limitations their patients may have relating to their ability to drive with glaucoma. According to the recent guidelines by the General Optical Council (GOC), clinicians are advised to make sure that the Driving and Vehicle Licensing Agency (DVLA) is informed about patients who do not meet the driving vision standards. There are several limitations in making a professional judgement about a patient's suitability to drive and in providing appropriate advice to patients. The main concern is discussing this sensitive issue with the patient based upon available clinical evidence e.g. vision or visual field and directing them to inform the DVLA of their condition or potentially advising them to stop driving. The purpose of this research is to investigate the two main issues 1. To explore patients' understanding of standards of vision for driving. 2. Comparing the standards of vision for driving estimated in the clinic with number plate vision. We propose to do a mixed methods analysis using a patient survey and quantitative investigation of driving vision standards.


Description:

The two main objectives that we propose to study in this project are 1. Descriptive understanding of patients' perception of their driving needs and their understanding of driving standards. This will be studied with the help of a survey questionnaire to learn about patients' driving needs, sight history, understanding of DVLA vision standards and the driving advice given to them. Understanding glaucoma patients' general perceptions about standards of vision for driving and their driving needs will help us to improve communication with the patients and to give the best possible advice about standards of vision for driving. 2. Quantitative comparison of standards of vision for driving as required by DVLA and clinical vision assessment in glaucoma patients. The limitations to meet the vision standard for driving will be assessed in glaucoma patients in the clinic and outside the clinic as required by DVLA standards of vision for driving. In the clinic, vision will be assessed by checking if the patient can binocularly read the 6/12 line on the vision chart and electronic number plate test used in the clinic. The results will be compared with a self-assessed number plate vision - a standard requirement to meet DVLA's standard of vision for driving. Understanding the clinical estimation of binocular vision, patients' ability to read the number plate in clinic and to self-assess their number plate vision will help the clinician to know patients' abilities and give evidence-based advice to the glaucoma patient about meeting the DVLA standards of vision.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 25, 2023
Est. primary completion date October 25, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 110 Years
Eligibility Inclusion criteria for Patient survey: - All patients attending the glaucoma clinic will be eligible for the survey. - Both drivers and non-drivers will be included in the study. Inclusion Criteria for Quantitative vision estimation: • Glaucoma patients with habitual vision of 6/19 or better at least in one eye (whether driving or not driving). Exclusion criteria for Patient survey: • All the patients attending glaucoma clinic, willing to participate in the study, will be eligible to participate in the survey and will not be excluded from the study. Exclusion Criteria for Quantitative vision estimation: • Patients with a binocular habitual visual acuity of less than 6/19 will not be able to eligible to participate in qualitative vision assessment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Driving assessment in glaucoma patient
One group of patient will be given questionnaire while the other group will respond to a questionnaire while the other group will have vision assessment. Patients could participate in both groups.

Locations

Country Name City State
United Kingdom Manchester Royal Eye Hospital Manchester

Sponsors (1)

Lead Sponsor Collaborator
Manchester University NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ability to read 6/12 or above in vision chart with both eyes. Binocular Vision assessment in Logmar testing 6 months
Primary Vision Chart score in each eye Unilateral Vision testing Logmar testing 6 months
Primary Ability to read the number plate in the clinic displayed in the VDU Ability to read the number plate in the clinic displayed in the VDU comparative visual display unit 6 months
Primary Ability to read the car number plate outside the clinic Ability to read the car number plate outside the clinic as per patients self assessment 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A